Stage IV Adult Lymphoblastic Lymphoma Terminated Phase Trials for Plerixafor (DB06809)

IndicationStatusPhase
DBCOND0028716 (Stage IV Adult Lymphoblastic Lymphoma)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01076270Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment